Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival
1 other identifier
observational
139
1 country
1
Brief Summary
The aim of this study is to compare the clinical features and postoperative survival outcomes between patients with spinal metastasis as the initial manifestation of malignancy and those with spinal metastasis occurring after an established diagnosis of malignancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedFirst Submitted
Initial submission to the registry
July 24, 2025
CompletedFirst Posted
Study publicly available on registry
August 3, 2025
CompletedAugust 3, 2025
July 1, 2025
7.2 years
July 24, 2025
July 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Overall Survival
Postoperative overall survival is defined as the time from the date of surgery for spinal metastasis to the date of death from any cause. Patients who are still alive at the last follow-up will be censored at that date. Survival status will be ascertained by clinical follow-up and/or review of medical records.
From the date of surgery until death or last follow-up, up to 5 years
Study Arms (2)
Spinal Metastasis as the First Presentation of Lung Malignancy
It refers to patients who first present with symptoms such as pain or spinal cord compression caused by spinal metastasis, leading to the initial detection of bone metastasis, and are subsequently diagnosed with lung cancer.
lung cancer who subsequently developed spinal metastasis
It refers to patients with a history of treatment for primary lung cancer who subsequently developed spinal metastasis during the course of the disease.
Eligibility Criteria
The study population will consist of adult patients diagnosed with lung cancer who have developed spinal metastasis. Participants will be selected from individuals treated at Guangdong Provincial People's Hospital. Eligible patients must have a diagnosis of lung cancer with spinal metastasis confirmed by pathological examination or imaging studies, and must have undergone surgical intervention for spinal metastasis.
You may qualify if:
- Age ≥ 18 years.
- Pathologically or radiologically confirmed diagnosis of lung cancer with spinal metastasis.
- Patients with spinal metastasis who underwent surgical intervention.
- Adequate medical records and follow-up data available.
You may not qualify if:
- Patients with spinal metastasis originating from non-lung primary tumors.
- Patients who did not receive surgical treatment for spinal metastasis.
- Incomplete clinical data or lost to follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510080, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 24, 2025
First Posted
August 3, 2025
Study Start
January 1, 2018
Primary Completion
March 30, 2025
Study Completion
April 30, 2025
Last Updated
August 3, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because of patient privacy concerns and local data protection regulations. Data may contain sensitive personal information that cannot be sufficiently anonymized to ensure participant confidentiality.